P2‐473: Novel methods to develop human monoclonal anti‐amyloid antibodies that target Aβ aggregates | Zendy

Levites Yona | Zendy; Jansen Karen | Zendy; CeballosDiaz Carolina | Zendy; Cruz Pedro | Zendy; Adekar Sharad | Zendy; Dessain Scott | Zendy; Golde Todd | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

P2‐473: Novel methods to develop human monoclonal anti‐amyloid antibodies that target Aβ aggregates

Author(s) -

Levites Yona,

Jansen Karen,

CeballosDiaz Carolina,

Cruz Pedro,

Adekar Sharad,

Dessain Scott,

Golde Todd

Publication year - 2011

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2011.05.1345

Subject(s) - antibody , monoclonal antibody , immunoglobulin light chain , amyloid (mycology) , phage display , chemistry , peptide , humanized antibody , amyloid precursor protein , recombinant dna , p3 peptide , immunotherapy , microbiology and biotechnology , peptide library , biochemistry , biology , peptide sequence , alzheimer's disease , immunology , medicine , immune system , disease , gene , pathology , inorganic chemistry

'Alzheimer''s & Dementia: The Journal of the Alzheimer''s Association 7 (2011) S464-S464. doi:10.1016/j.jalz.2011.05.1345'Received by publisher: 0000-01-01Harvest Date: 2016-01-04 12:23:42DOI: 10.1016/j.jalz.2011.05.1345Page Range: S464-S46

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research